Skip to content
value.today

Exagen Inc. vs Neuronetics, Inc.

Add a company

Market value, revenue, profit, valuation and financial strength side by side, each from the company's own filings or market data, with its date.

In short

  • Exagen Inc. is the larger company by market value: $218 M against $162 M for Neuronetics, Inc., 1.4 times as much (market caps of Oct 16, 2026 for Exagen Inc. and Oct 23, 2026 for Neuronetics, Inc.).
  • Neuronetics, Inc. had more revenue: $149 M against $67 M for Exagen Inc., both in the year to December 2025.
  • Both made a net loss: $20 M for Exagen Inc. and $39 M for Neuronetics, Inc.
  • Neuronetics, Inc. keeps more of each dollar of sales: a net margin of -26.1% against -30.0% for Exagen Inc.
  • Neuronetics, Inc.'s revenue grew faster in its latest fiscal year: +99.2% against +19.7% for Exagen Inc.
  • On the Piotroski F-score, a nine-point test of improving finances, Exagen Inc. scores 3 and Neuronetics, Inc. 4. Both are in the distress zone of the Altman Z-score.

Market value, the same start = 100

From Jan 2020: how each one's value moved, whatever its size.

0751492242992020202120222023202420252026Exagen Inc. 67Neuronetics, Inc. 192

Revenue by fiscal year

US$ billions, as reported in each year's annual results.

$0B$0B$0B$0B$0B201720182019202020212022202320242025Exagen Inc. $0BNeuronetics, Inc. $0B

Side by side

Side-by-side comparison; ▲ marks the best value of a measure where higher or lower is better
MeasureExagen Inc.
XGN · #15,928 in the world
Neuronetics, Inc.
STIM · #17,042 in the world
Profile
Country🇺🇸 USA🇺🇸 USA
SectorHealthcareHealthcare
IndustryDiagnostics and ResearchDiagnostics and Research
Founded20022003
Size
Market cap$218 M$162 M
Revenue$67 M$149 M
Net income$-20 M▲ best$-39 M
Employees220—
Valuation
Price to sales3.0×1.0×
Price to book12.5×7.2×
Free cash flow yield-6.5%▲ best-13.1%
Profitability
Gross margin58.3%▲ best48.5%
Operating margin-21.1%-21.1%▲ best
Net margin-30.0%-26.1%▲ best
Return on equity-147.8%▲ best-155.7%
Growth
Revenue growth19.7%99.2%▲ best
Revenue growth, 3 years a year13.5%31.8%▲ best
Financial strength
Debt to equity1.3×▲ best2.9×
Interest cover—-4.1×
Cash
Free cash flow margin-21.4%-14.2%▲ best
Strength scores
Piotroski F-score3 of 94 of 9▲ best
Altman Z-score zonedistressdistress
Data as ofMarket cap Oct 2026; ratios FY2025Market cap Oct 2026; ratios FY2025

▲ marks the better of the two where higher or lower is better; size and valuation multiples are marked for neither

Questions and answers#

Which is bigger, Exagen Inc. or Neuronetics, Inc.?

Exagen Inc. is the larger company by market value: $218 M against $162 M for Neuronetics, Inc., 1.4 times as much (market caps of Oct 16, 2026 for Exagen Inc. and Oct 23, 2026 for Neuronetics, Inc.).

Which makes more money, Exagen Inc. or Neuronetics, Inc.?

Neuronetics, Inc. had more revenue: $149 M against $67 M for Exagen Inc., both in the year to December 2025. Both made a net loss: $20 M for Exagen Inc. and $39 M for Neuronetics, Inc.

Which is more profitable, Exagen Inc. or Neuronetics, Inc.?

Neuronetics, Inc. keeps more of each dollar of sales: a net margin of -26.1% against -30.0% for Exagen Inc.

Which is growing faster, Exagen Inc. or Neuronetics, Inc.?

Neuronetics, Inc.'s revenue grew faster in its latest fiscal year: +99.2% against +19.7% for Exagen Inc.

Which is financially stronger, Exagen Inc. or Neuronetics, Inc.?

On the Piotroski F-score, a nine-point test of improving finances, Exagen Inc. scores 3 and Neuronetics, Inc. 4. Both are in the distress zone of the Altman Z-score.

Sources#

Every figure on this page comes from these, with the date shown next to it.